Full Text View
Tabular View
No Study Results Posted
Related Studies
Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00470847   Information provided by Dana-Farber Cancer Institute

First Received on May 7, 2007.   Last Updated on September 11, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Brain Metastases
Additional conditions recognized in this trial
Brain Neoplasms
Breast Neoplasms
Neoplasm Metastasis
Neoplasms, Second Primary
More general conditions related to this trial
Brain Diseases
Breast Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Neoplasms
Neoplasms by Site
Neoplastic Processes
Nervous System Diseases
Nervous System Neoplasms
Pathologic Processes
Skin Diseases
Interventions listed in this trial
Lapatinib
Whole Brain Radiation
More general drug interventions related to this trial
Antineoplastic Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Nancy Lin, MD
Brigham and Women's Hospital
Breast Cancer Research Foundation
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services